Cargando…
Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
Antibody microarrays have the potential to enable comprehensive proteomic analysis of small amounts of sample material. Here, protocols are presented for the production, quality assessment, and reproducible application of antibody microarrays in a two-color mode with an array of 1,800 features, repr...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877986/ https://www.ncbi.nlm.nih.gov/pubmed/20164060 http://dx.doi.org/10.1074/mcp.M900419-MCP200 |
_version_ | 1782181833569468416 |
---|---|
author | Schröder, Christoph Jacob, Anette Tonack, Sarah Radon, Tomasz P. Sill, Martin Zucknick, Manuela Rüffer, Sven Costello, Eithne Neoptolemos, John P. Crnogorac-Jurcevic, Tatjana Bauer, Andrea Fellenberg, Kurt Hoheisel, Jörg D. |
author_facet | Schröder, Christoph Jacob, Anette Tonack, Sarah Radon, Tomasz P. Sill, Martin Zucknick, Manuela Rüffer, Sven Costello, Eithne Neoptolemos, John P. Crnogorac-Jurcevic, Tatjana Bauer, Andrea Fellenberg, Kurt Hoheisel, Jörg D. |
author_sort | Schröder, Christoph |
collection | PubMed |
description | Antibody microarrays have the potential to enable comprehensive proteomic analysis of small amounts of sample material. Here, protocols are presented for the production, quality assessment, and reproducible application of antibody microarrays in a two-color mode with an array of 1,800 features, representing 810 antibodies that were directed at 741 cancer-related proteins. In addition to measures of array quality, we implemented indicators for the accuracy and significance of dual-color detection. Dual-color measurements outperform a single-color approach concerning assay reproducibility and discriminative power. In the analysis of serum samples, depletion of high-abundance proteins did not improve technical assay quality. On the contrary, depletion introduced a strong bias in protein representation. In an initial study, we demonstrated the applicability of the protocols to proteins derived from urine samples. We identified differences between urine samples from pancreatic cancer patients and healthy subjects and between sexes. This study demonstrates that biomedically relevant data can be produced. As demonstrated by the thorough quality analysis, the dual-color antibody array approach proved to be competitive with other proteomic techniques and comparable in performance to transcriptional microarray analyses. |
format | Text |
id | pubmed-2877986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | The American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-28779862010-06-02 Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies Schröder, Christoph Jacob, Anette Tonack, Sarah Radon, Tomasz P. Sill, Martin Zucknick, Manuela Rüffer, Sven Costello, Eithne Neoptolemos, John P. Crnogorac-Jurcevic, Tatjana Bauer, Andrea Fellenberg, Kurt Hoheisel, Jörg D. Mol Cell Proteomics Research Antibody microarrays have the potential to enable comprehensive proteomic analysis of small amounts of sample material. Here, protocols are presented for the production, quality assessment, and reproducible application of antibody microarrays in a two-color mode with an array of 1,800 features, representing 810 antibodies that were directed at 741 cancer-related proteins. In addition to measures of array quality, we implemented indicators for the accuracy and significance of dual-color detection. Dual-color measurements outperform a single-color approach concerning assay reproducibility and discriminative power. In the analysis of serum samples, depletion of high-abundance proteins did not improve technical assay quality. On the contrary, depletion introduced a strong bias in protein representation. In an initial study, we demonstrated the applicability of the protocols to proteins derived from urine samples. We identified differences between urine samples from pancreatic cancer patients and healthy subjects and between sexes. This study demonstrates that biomedically relevant data can be produced. As demonstrated by the thorough quality analysis, the dual-color antibody array approach proved to be competitive with other proteomic techniques and comparable in performance to transcriptional microarray analyses. The American Society for Biochemistry and Molecular Biology 2010-06 2010-02-16 /pmc/articles/PMC2877986/ /pubmed/20164060 http://dx.doi.org/10.1074/mcp.M900419-MCP200 Text en © 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) applies to Author Choice Articles |
spellingShingle | Research Schröder, Christoph Jacob, Anette Tonack, Sarah Radon, Tomasz P. Sill, Martin Zucknick, Manuela Rüffer, Sven Costello, Eithne Neoptolemos, John P. Crnogorac-Jurcevic, Tatjana Bauer, Andrea Fellenberg, Kurt Hoheisel, Jörg D. Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies |
title | Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies |
title_full | Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies |
title_fullStr | Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies |
title_full_unstemmed | Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies |
title_short | Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies |
title_sort | dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877986/ https://www.ncbi.nlm.nih.gov/pubmed/20164060 http://dx.doi.org/10.1074/mcp.M900419-MCP200 |
work_keys_str_mv | AT schroderchristoph dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT jacobanette dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT tonacksarah dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT radontomaszp dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT sillmartin dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT zucknickmanuela dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT ruffersven dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT costelloeithne dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT neoptolemosjohnp dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT crnogoracjurcevictatjana dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT bauerandrea dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT fellenbergkurt dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies AT hoheiseljorgd dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies |